Search

everythinglearnresearchcommunity

for

Search:↓

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

Microneedles offer a promising, less invasive way to treat and monitor psoriasis.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Acne may signal underlying metabolic issues, and lifestyle changes can help manage both.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Finasteride is effective for hair regrowth, but some believe it may cause persistent symptoms due to psychological factors.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Olfactory receptors found outside the nose may offer new treatments for diseases like cancer and help in wound healing and hair growth.

Finasteride, a hair loss drug, can cause sexual side effects like erectile dysfunction in 2.1%-3.8% of users, but these usually go away with time or if the drug is stopped. Despite this, its impact on sexual function is minimal for most men.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

PSA is best for detecting prostate cancer recurrence and evaluating treatment response.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Higher urethral PSA levels after prostate removal may be linked to more scalp hair loss and more PSA in urethral glands.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Serenoa repens extract, alone or with other supplements, improves urinary symptoms and lowers PSA levels.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

PSA testing is a reliable method for detecting prostate cancer, and opioids may lower PSA levels, but triglycerides don't affect prostate cancer risk.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Low dose finasteride causes only minor changes in PSA levels in men over 50 with BPH.

Higher C-peptide levels in African-American men and higher HbA1c levels in Caucasian men are linked to lower PSA levels.

Finasteride lowers PSA levels about the same whether taken at 1 mg or 5 mg daily.

Low-dose finasteride lowers PSA levels, which can make prostate cancer harder to detect.